Cargando…

COPD exacerbation frequency and its association with health care resource utilization and costs

BACKGROUND: Chronic obstructive pulmonary disease (COPD) exacerbations account for a substantial proportion of COPD-related costs. OBJECTIVE: To describe COPD exacerbation patterns and assess the association between exacerbation frequency and health care resource utilization (HCRU) and costs in pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhamane, Amol D, Moretz, Chad, Zhou, Yunping, Burslem, Kate, Saverno, Kim, Jain, Gagan, Renda, Andrew, Kaila, Shuchita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671762/ https://www.ncbi.nlm.nih.gov/pubmed/26664109 http://dx.doi.org/10.2147/COPD.S90148

Ejemplares similares

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population
por: Schwab, Phil, et al.
Publicado: (2017)

Development and Validation of a Predictive Model to Identify Individuals Likely to Have Undiagnosed Chronic Obstructive Pulmonary Disease Using an Administrative Claims Database
por: Moretz, Chad, et al.
Publicado: (2015)

Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients
por: Dhamane, Amol D, et al.
Publicado: (2016)

Development and validation of a predictive model to identify patients at risk of severe COPD exacerbations using administrative claims data
por: Annavarapu, Srinivas, et al.
Publicado: (2018)

Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD
por: Moretz, Chad, et al.
Publicado: (2019)

Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population
por: Sethi, Sanjay, et al.
Publicado: (2022)

COPD management costs according to the frequency of COPD exacerbations in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2014)

COPD management costs according to the frequency of COPD exacerbations in UK primary care [Corrigendum]
Publicado: (2014)

Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy
por: Palli, Swetha R, et al.
Publicado: (2021)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA
por: Hanania, Nicola A, et al.
Publicado: (2023)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort
por: Han, MeiLan K., et al.
Publicado: (2017)

Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD
por: Ke, Xuehua, et al.
Publicado: (2016)

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy
por: Moretz, Chad, et al.
Publicado: (2020)

Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations
por: Fuoco, Morgan Justice, et al.
Publicado: (2021)

Clinical Features according to the Frequency of Acute Exacerbation in COPD
por: Lee, Seung Jun, et al.
Publicado: (2012)

No association between exacerbation frequency and stroke in patients with COPD
por: Windsor, Claire, et al.
Publicado: (2016)

Impact of bronchiectasis on the frequency and severity of respiratory exacerbations in COPD
por: Labaki, Wassim W, et al.
Publicado: (2018)

Lifestyle Changes and Exacerbation Frequency of COPD in Times of the Pandemic
por: Akyıl, Fatma Tokgöz, et al.
Publicado: (2022)

Utility of the CAT in the therapy assessment of COPD exacerbations in China
por: Tu, You-Hui, et al.
Publicado: (2014)

Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study
por: Johansson, Gunnar, et al.
Publicado: (2018)

Association between lung function and exacerbation frequency in patients with COPD
por: Hoogendoorn, Martine, et al.
Publicado: (2010)

Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD
por: Lonergan, Mike, et al.
Publicado: (2020)

Disproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare cost
por: Darnell, Kyle, et al.
Publicado: (2013)

Clinical diaries in COPD: compliance and utility in predicting acute exacerbations
por: Walters, E Haydn, et al.
Publicado: (2012)

Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population
por: Moll, Keran, et al.
Publicado: (2015)

Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
por: Reynolds, Shannon L., et al.
Publicado: (2017)

Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History
por: Sethi, Sanjay, et al.
Publicado: (2023)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Initiation of triple therapy maintenance treatment among patients with COPD in the US
por: Simeone, Jason C, et al.
Publicado: (2016)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
por: Eltboli, Osama, et al.
Publicado: (2014)

Effect of thyroid function on COPD exacerbation frequency: a preliminary study
por: Sarinc Ulasli, Sevinc, et al.
Publicado: (2013)

Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD
por: Singh, R., et al.
Publicado: (2021)

The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study
por: Schmidt, Sigrun Alba Johannesdottir, et al.
Publicado: (2014)

Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes
por: Anzueto, A, et al.
Publicado: (2009)

Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort
por: Wilkinson, Tom M.A., et al.
Publicado: (2019)

Real-world Duration of Use and Dosing Frequency of Daratumumab in Patients With Multiple Myeloma in the United States
por: Fonseca, Rafael, et al.
Publicado: (2023)

Consolidation and Exacerbation of COPD
por: Hurst, John R.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8id0hda9jp5ugeovcmr68hlkc7